These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17076230)

  • 1. [Ivabradin (coraxan). One more new approach to fighting myocardial ischemia in patients with ischemic heart disease].
    Eliseev OM
    Ter Arkh; 2006; 78(9):78-86. PubMed ID: 17076230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical efficacy of ivabradin and nebivolol addition in combined treatment of ischemic heart disease patients with left ventricular dysfunction].
    Tatarchenko IP; Pozdniakova NV; Biriuchenko MV; Kapelovich VIu; Sekerko SA; Kupaeva RA
    Ter Arkh; 2008; 80(9):40-4. PubMed ID: 19555036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ivabradin on mechanism of inter-ventricle interaction and respiratory function in conditions of cardio-respiratory pathology (results of Russian pilot study)].
    Kolomoets NM; Baksheev VI; Kartashov VT; Zarubina EG; Arkad'eva NM; Kostycheva TV; Shvediuk VM
    Voen Med Zh; 2008 Feb; 329(2):47-53. PubMed ID: 18416113
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical efficiency of ivabradine in patients with cardiorespiratory pathology].
    Kolomoets NM; Bakshiev VI; Zarubina EG; Usenko SV; Arkad'eva NM; Kostycheva TV; Uvaĭsova KU
    Klin Med (Mosk); 2008; 86(5):44-54. PubMed ID: 18589718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivabradine significantly improves cardiac function in patients with ischemic heart disease: a meta-analysis of randomized controlled trials.
    Peng L; Yan B; Song A; Li L; Zeng L; Wang G
    Int J Cardiol; 2013 Oct; 168(3):3007-10. PubMed ID: 23647594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical efficacy of ivabradine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
    Kolomoets NM; Baksheev VI; Zarubina EG
    Kardiologiia; 2008; 48(3):13-9. PubMed ID: 18429751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological correction of heart rate in myocardial ischemia].
    Ter Arkh; 2012; 84(4):68-73. PubMed ID: 22774495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of lower heart rate to mortality and the benefits of exclusive heart rate reduction in ischaemia.
    Cardiovasc J Afr; 2007; 18(5):338-40. PubMed ID: 17985037
    [No Abstract]   [Full Text] [Related]  

  • 10. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
    Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience of the use of ivabradine in clinical practice].
    Makolkin VI; Petriĭ VV; Anderzhanova AA; Dranko ON
    Kardiologiia; 2008; 48(6):24-7. PubMed ID: 18729832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Specific bradycardic drug zatebradin: cardiac rhythm variability, antifibrillatory, and antiischemic effects].
    Tsorin IB; Palka IP; Kirsanova GIu; Chichkanov GG
    Eksp Klin Farmakol; 2008; 71(1):31-5. PubMed ID: 18365484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ivabradine on left ventricular function in patients with ischemic heart disease.
    Yang Y; Peng DQ
    Int J Cardiol; 2013 Oct; 168(5):5050-1. PubMed ID: 23968718
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "Effects of Ivabradine on left ventricular function in patients with ischemic heart disease".
    Peng L; Yan B; Wang G
    Int J Cardiol; 2015 Jul; 191():201-2. PubMed ID: 25974195
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-ischemic effect of Aurantii Fructus on contractile dysfunction of ischemic and reperfused rat heart.
    Kang M; Kim JH; Cho C; Chung HS; Kang CW; Kim Y; Shin M; Hong M; Bae H
    J Ethnopharmacol; 2007 May; 111(3):584-91. PubMed ID: 17291701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulse slowing drugs in therapy of ischemic heart disease].
    Kuleshova EV
    Kardiologiia; 2013; 53(10):82-8. PubMed ID: 24645558
    [No Abstract]   [Full Text] [Related]  

  • 17. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pacemaker current (i(f)) blockade causes heart rate reduction without negative inotropism: a new perspective in the treatment of ischemic heart disease.
    Goethals M; Van Bogaert PP; Snoeck J
    Acta Cardiol; 1993; 48(1):144-6. PubMed ID: 8447184
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics and outcome of chronic ischemic heart failure in angina-free patients.
    Bestetti RB; Yoshitake R; Cardoso TA; Freitas PF; Cordeiro JA; Theodoropoulos TA
    Int J Cardiol; 2008 Aug; 128(1):145-6. PubMed ID: 17692970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ischemic heart disease: old traditions and new trends].
    Belenkov IuN
    Ter Arkh; 2005; 77(9):5-8. PubMed ID: 16281480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.